(9Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (9Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate
• 英文别名: (Z,11E)-11-[(3S)-3-[(Z)-pent-2-enyl]oxiran-2-ylidene]undec-9-enoic acid
• 化学式: C₁₈H₂₈O₃
• 分子量: 292.4
• InChiKey: YZBZORUZOSCZRN-DSRRMRMISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  21
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Nutraceutical composition and methods of use
  申请人：Dacy Tech Party Ltd.

  公开号：US10376550B2

  公开（公告）日：2019-08-13

  A method of modulating inflammation in an organism, which includes administering to an organism a composition including a therapeutic amount of a hydrolyzed extract from the plant Biota orientalis. Several key components of the hydrolyzed extract of Biota orientalis have been identified that have also been shown to have an effect in dramatically reducing inflammatory responses.

  一种调节生物体内炎症的方法，包括向生物体施用一种组合物，该组合物包括治疗量的东方曙红植物水解提取物。已确定东方糙叶榕水解提取物中的几种关键成分也被证明具有显著降低炎症反应的作用。
• NUTRACEUTICAL COMPOSITION AND METHODS OF USE
  申请人：Dacy Tech Pty Ltd

  公开号：EP2231173A1

  公开（公告）日：2010-09-29
• US8431169B2
  申请人：——

  公开号：US8431169B2

  公开（公告）日：2013-04-30
• [EN] NUTRACEUTICAL COMPOSITION AND METHODS OF USE<br/>[FR] COMPOSITION NUTRACEUTIQUE ET SES MÉTHODES D'UTILISATION
  申请人：DACY TECH PTY LTD

  公开号：WO2009073930A1

  公开（公告）日：2009-06-18

  A method of treatment for cartilage degradation in an organism, which includes administering to an organism a composition including a therapeutic amount of an extract from the plant Biota orientalis. Several key components of the extract of Biota orientalis have been identified that have also been shown to have an effect in dramatically reducing and reversing cartilage degradation.